Purple Biotech to Present at the Jefferies London Healthcare Conference

(marketscreener.com) REHOVOT, Israel, Nov. 10, 2022 -- Purple Biotech Ltd. , a clinical-stage company developing first-in-class, effective and durable therapies by harnessing the power of the tumor microenvironment to overcome tumor immune evasion and drug resistance, today announced that Gil Efron, Chief Executive Officer of Purple Biotech, and Fabien Sebille,...https://www.marketscreener.com/quote/stock/PURPLE-BIOTECH-LTD-24978833/news/Purple-Biotech-to-Present-at-the-Jefferies-London-Healthcare-Conference-42269259/?utm_medium=RSS&utm_content=20221110